© 2002 Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology • 2:2 (2002) 1–6 • PII. S1110724302201023 • http://jbb.hindawi.com
Nucleotide Excision Repair, Genome Stability, and
Human Disease: New Insight from Model Systems
David J. Garfinkel1and Adam M. Bailis2∗
1Gene Regulation and Chromosome Biology Laboratory, NCI at Frederick, Frederick, MD 21702, USA
2Division of Molecular Biology, Beckman Research Institute of the City of Hope,
City of Hope National Medical Center, Duarte, CA 91010, USA
Revised 26 November 2001; Accepted 11 December 2001
Nucleotide excision repair (NER) is one of several DNA repair pathways that are universal throughout phylogeny. NER has a broad
to UV radiation. The loss of this activity in NER-defective mutants gives rise to characteristic sensitivities to UV that, in humans, is
manifested as a greatly elevated sensitivity to exposure to the sun. Xeroderma pigmentosum (XP), Cockaynes syndrome (CS), and
trichothiodystrophy (TTD) are three, rare, recessively inherited human diseases that are linked to these defects. Interestingly, some
of the symptoms in afflicted individuals appear to be due to defects in transcription, the result of the dual functionality of several
components of the NER apparatus as parts of transcription factor IIH (TFIIH). Studies with several model systems have revealed
that the genetic and biochemical features of NER are extraordinarily conserved in eukaryotes. One system that has been studied very
and defective transcription, other interesting phenotypes have also been observed. Elevated mutation and recombination rates, as
well as increased frequencies of genome rearrangement by retrotransposon movement and recombination between short genomic
sequences have been documented. The potential relevance of these novel phenotypes to disease in humans is discussed.
DNA REPAIR AND DISEASE
The maintenance of the integrity of DNA is of a para-
itory for all genetic information. A network of biochemical
pathways exists in all cells to maintain the informational and
in part, by the types of modifications to the DNA to which
they respond. The dissection of these pathways has involved
a coordinated biochemical, genetic, and molecular biologi-
cal approach where specific enzymatic defects are correlated
with mutations at particular chromosomal loci, and distinc-
tive cellular phenotypes. In humans, the specific DNA repair
defects have been correlated with particular inherited dis-
eases. Hereditary nonpolyposis colorectal cancer, for exam-
ple, is a disorder associated with mutations in genes encod-
ing components of the mismatch repair apparatus that lead
in genome instability . Similarly, a trio of phenotypically
disparate diseases, XP, CS, and TTD have been connected
with mutations in genes that encode subunits of the NER
and TFIIH apparatus, that confer measurable defects in NER
diseases most likely reflects the multiple biochemical defects
caused by the mutations, some of which have not been ex-
tensively explored. This work focus on some of the less de-
scribed effects of mutations in the NER/TFIIH apparatus
on genome stability, and their potential implications with re-
spect to human disease.
NUCLEOTIDE EXCISION REPAIR
NER plays a critical role in the maintenance of genomic
integrity because of its broad substrate specifity. It plays an
important role in the removal of such diverse lesions as UV
light induced photoproducts as well as chemically induced
bulky adducts, crosslinks, and oxidized bases. NER has been
functionally conserved throughout phylogeny, although the
apparatus in prokaryotes and eukaryotes is substantially dif-
to 30 proteins and has been reconstituted in vitro[5, 6].NER
occurs in the context of two distinct pathways related to the
way the lesions are identified. General genome repair (GGR)
ognized by the XPC/HHR23B complex . Transcription
coupled repair (TCR) is focused exclusively on the repair of
II stalled at a lesion by the CSA and CSB proteins [9, 10].The
XPA protein then orchestrates the assembly of a complex in-
cluding the single-stranded DNA binding protein RPA and
the core of the TFIIH complex at the site of the lesion .
ATP-dependent process that involves the helicase activities of
2 D. J. Garfinkel and A. M. Bailis2:2 (2002)
the XPB and XPD proteins, components of the TFIIH core
complex [12, 13]. Interestingly, only the helicase activity of
XPB is required for TFIIH-mediated melting of promoter
DNA during the initiation of transcription, while XPD he-
licase activity plays a minor role in RNA polymerase II pro-
moter escape . Two structure-specific endonucleases, the
ERCC1/XPF heterodimer, that cleaves on the 3’ side of the
lesion,andXPG,thatcleavesonthe 5’ sideofthe lesion,are
responsible for the removal of a 24–32 base oligonucleotide
containing the lesion [15, 16]. The resulting gap is filled by
DNA polymerases δ and ε, and repair is completed by liga-
NER PHOTOSENSITIVITY SYNDROMES
XP, CS, and TTD have been ascribed to changes in NER
and TFIIH function. Complementation analysis, conducted
by analyzing the phenotypes of cells derived from the fusion
of cells from different patients, identified several comple-
tified for XP. Two complementation groups, CS-A and CS-B,
have been identified for CS. Three complementation groups,
XP-B, XP-D, and XP-G, have been determined for the com-
bined CS/XP patients. Three complementation groups, XP-
B, XP-D, and TTD-A, have been identified for TTD. Most of
the genes corresponding to these complementation groups
have been cloned and the mutations responsible for disease
in individual kindreds have been identified.
XP, CS, and TTD patients have distinct symptoms that
likely reflect the participation of the mutant proteins in mul-
tiple biochemical processes. In patients, symptoms can often
be correlated with specific biochemical defects. An example
terations of the texture and pigmentation of the skin that are
. CS patients present symptoms of poor growth and de-
velopmental deformity that are most likely due to defec-
tive transcription. Accordingly, extracts of cells from patients
with particular CSA and CSB mutations have been shown to
support reduced levels of RNA polymerase II mediated tran-
scription, as have cells from patients with combined XP/CS
disease that are due to a mutation in XPB . TTD patients
suffer from brittle hair and nails, scaly skin and developmen-
tal abnormalities that are probably related to defects in NER
was correlated with temperature sensitive transcription and
STUDIES WITH MODEL SYSTEMS
The extraordinary level of conservation of the NER and
TFIIH apparatus among eukaryotes permits the extensive
use of model systems to better explore the genetic and bio-
chemical control of theses processes. Studies in rodents, flies,
plants, and fungi have all contributed to the understanding
of the role played by the NER and TFIIH apparatus in eu-
karyotes [21, 22, 23, 24, 25, 26]. However, trangenic mice
and budding yeast have been particularly helpful in study-
ing NER and TFIIH at the molecular level, as well as their
effects on the phenotype of the organism. For example, in a
leles of XPA or CSB were found to be extremely sensitive to a
carcinogen that forms bulky adducts on DNA, while an XPC
null strain was not . This suggests that XPA-dependent
and CSB-dependent TCR is critical for survival to exposure
to an important class of carcinogens, while XPC-dependent
GGR is not. Such studies are very important in determining
how mammals respond to particular types of DNA damage.
Mice have also been used to further explore the phenotypic
effects of NER mutations known to cause disease in humans.
gous for an XPD mutation analogous to the one found in
several NER-deficient TTD patients . The mice exhib-
ited hypersensitivity to UV exposure and a cellular NER de-
fect that was very similar to the TTD symptomology but,
also exhibited a marked propensity toward UV-induced and
carcinogen-induced skin cancer that was not observed in pa-
tients. This suggests the possibility that the NER defects ob-
served in TTD patients could lead to cancer, an observation
of potential clinical importance.
malian cells has been essentially contemporaneous. The ob-
servation that NER and transcription are genetically and
biochemically linked occurred nearly simultaneously in the
two systems, significantly accelerating the description of eu-
karyotic NER and transcription initiation at the molecular
level [29, 30]. The degree of similarity between the appa-
ratus in humans and yeast is extraordinary, permitting in-
vestigators to examine the impact of disease causing alleles
of human NER genes on yeast. In one study, two TTD al-
leles of XPD were unable to complement the lethal effect
of a null allele of the RAD3 gene, the budding yeast ho-
molog of XPD, while wild-type and helicase-defective alle-
les of XPD were able to complement . Since the essential
function of Rad3 /XPD is thought to be its role in tran-
les confer a transcription defect, and, therefore, that the dis-
ease may be due to defective transcription of a critical gene,
NER, TFIIH AND THE MAINTENANCE OF GENOME
STABILITY IN BUDDING YEAST
The careful study of NER in budding yeast has revealed
its impact on cellular processes yet to be recognized in other
sight into clinically important roles for the human NER ap-
the disease phenotype is complex as in CS and TTD. An im-
portant example is provided by the RAD1 and RAD10 genes,
2:2 (2002) Nucleotide Excision Repair, Genome Stability, and Human Disease. New insight from model systems3
I IaII IIIIVV VI
3551 6988 225239 455468 533554587 613 654671
35 51 68
240457 470535 556 589 615 656 673
Figure 1. Amino acid changes in the human XPD and budding yeast Rad3 helicases that lead to phenotypic changes. The primary amino acid sequences of
human XPD and yeast Rad3 are represented by the black bar. The seven conserved helicase domains are represented by white boxes and are named according
to the accepted nomenclature . The positions of these domains in the primary sequence are listed in bold print as described in . Positions of altered
residues in the primary sequence of XPD in XP, XP/CS, and TTD patients  are marked with a light hash mark above the black bar. The corresponding
diseases are marked with an “X” for XP, a “C” for XP/CS, and a “T” for TTD. The amino acid changes are listed in parentheses. Changes in the Rad3 primary
sequence [38, 39] are represented by hash marks below the black bar. The corresponding phenotypic changes are denoted by a “U” for UV sensitive, an “R”
for elevated recombination, and/or mutation, and a “T” for transcription defective. Corresponding amino acid changes are listed in parentheses.
homologs of XPF and ERCC1. Null mutations in RAD1
of homologous recombination [32, 33]. Studies analyzing
the recombinational repair of defined double-strand breaks
(DSBs) revealed that RAD1 and RAD10 were required to re-
move nonhomologous sequences from the ends of recom-
bining molecules, an important step in the creation of cer-
a critical role in recombination between short sequences,
which is likely to be vital for the maintenance of genome sta-
bility . All of these effects are apt to be related to the role
of the Rad1-Rad10 nuclease in the cleavage of important re-
combination intermediates [34, 35, 36].
The TFIIH machinery has also been implicated in the
maintenance of genome stability. Mutant alleles of RAD3,
SSL1, and SSL2 (homologs of XPD, P44, and XPB) have
been isolated that confer elevated rates of mutation and
recombination. Several rad3
that exhibit increased rates of mutation and/or recombi-
nation but not defective transcription nor NER, indicat-
ing that Rad3 possesses important cellular activities that are
mutants have been isolated8
independent of transcription and NER [37, 38]. Interest-
ingly, a pair of these mutant alleles, rad3-101 (S74F) and
rad3-102 (H661Y), accumulate DSBs and are synthetically
lethal in combination with mutations in recombinational
repair genes, strongly suggesting that Rad3 influences ei-
ther the creation of DSBs, or their processing by homol-
ogous recombination . Another allele of RAD3, rad3-
G595R, blocks the degradation of DSBs, which stimulates
genome rearrangement by recombination between short re-
peated sequences [35, 36, 37, 38, 39, 40, 41]. The anal-
ogous mutations in XPD are of potential medical impor-
tance as they would be within regions that encode con-
served helicase domains of the protein that are mutated in
XP, TTD, and XP/CS patients (Figure 1), [42, 43, 44]. Since
specific mutations in SSL1 and SSL2 that encode additional
members of the heteromeric core of budding yeast TFIIH
 also stimulate short-sequence recombination (SSR) by
blocking the degradation of DSBs [40, 41], it appears that
TFIIH acts to maintain genome stability by restricting re-
combination between repetitive DNA sequences. We specu-
late that SSR could potentially contribute to the symptoms
4D. J. Garfinkel and A. M. Bailis 2:2 (2002)
observed in XP, XP-CS, and TTD patients, as SSR in the
human genome has been found to lead to a variety of dis-
of the retrotransposon Ty1, TFIIH plays an additional, crit-
ical role in the maintenance of genome stability in budding
yeast. Ty1 can move either by integrase mediated transpo-
sition, or by insertion of Ty cDNA into existing Ty or δ ele-
bination . Components of TFIIH were discovered to play
a role in restricting Ty mobility when specific rad3 and ssl2
. Other rad3 and ssl2 mutants that confer extreme UV
sensitivity do not stimulate Ty mobility, separating the NER
and Ty maintenance functions of these genes. The increases
in Ty mobility were correlated with a substantial elevation of
the steady-state level of Ty1 cDNA, suggesting either that the
rad3- rtt (regulator of Ty transposition) and ssl2- rtt mu-
tations increase the synthesis of Ty1 cDNA, or decrease its
degradation. Importantly, the level of Ty1 RNA and Ty1 pro-
teins remained unchanged in the rad3 and ssl2 mutants. An-
other interesting observation is that other NER genes, such
as RAD2 and RAD1 do not appear to be involved in Ty trans-
In a subsequent study, the increased level of Ty1 cDNA
was found not to be due to increased cDNA synthesis sug-
gesting that TFIIH plays a role in the degradation of Ty1
cDNA . This same study linked TFIIH-control of SSR
and Ty1 movement by showing that rad3-G595R and ssl2-
rtt increase both SSR and Ty1 movement while increasing
the stability of both Ty1 cDNA and DSBs. It remains unclear
whether TFIIH plays a direct or an indirect role in the degra-
dation of the ends of DNA molecules, however, the helicase
activities of Rad3 and Ssl2 suggest that TFIIH could play a
role in opening the ends of DNA molecules, thereby facili-
tating their processing by exonucleases.
Blocking the degradation of DSBs and Ty1 cDNAs could
enhance Ty1 movement and SSR in multiple ways. It could
preserve sequences at the ends of the molecules that are im-
portant for SSR and Ty1 movement. For example, a DSB in
a short repetitive sequence creates ends that are never far
from the border of homology with potential donor repeats,
their ability to pair and recombine. Similarly, loss of the se-
quences at the ends of Ty1 cDNA would block transposition
by Ty1 integrase. Another way (that increasing the stability
of DNA ends might elevate SSR and Ty mobility) could be
by prolonging the signal that elicits the DNA damage check-
point. Pausing the cell cycle for a protracted period may im-
prove the likelihood that the ends of DSBs in short repeats
can find homologous sequences, or that the Ty1 preintegra-
tion complex can complete a transposition event. Changes
in checkpoint activity have been shown to affect the fre-
quencies of other genome rearrangements . These and
other mechanisms could be working simultaneously to in-
crease genome rearrangement in rad3 and ssl2 mutant bud-
ding yeast. By extension, similar defects in the cells of XP,
XP-CS, or TTD patients with mutations in the XPD or XPB
genes might contribute to these diseases.
This research was sponsored in part by the National Can-
cer Institute, Department of Health and Human Services.
AMB is funded by Public Health Service Grant GM57484. 13
 Parsons R, Li GM, Longley MJ, et al. Hypermutability
and mismatch repair deficiency in RER+ tumor cells.
 Eveno E, Bourre F, Quillet X. Differential removal of
ultraviolet photoproducts in genetically related xero-
derma pigmentosum and trichothiodystrophy diseases.
Cancer Res. 1995;55(19):4325–4332.
 Cooper PK, Nouspikel T, Clarkson SG, Leadon SA. De-
fective transcription-coupled repair of oxidative base
damage in Cockayne syndrome patients from XP group
G. Science. 1997;275(5302):990–993.
tations in XPB and XPD helicases found in xeroderma
pigmentosum patients impair the transcription func-
tion of TFIIH. EMBO J. 1999;18(5):1357–1366.
 Aboussekhra A, Biggerstaff M, Shivji MK, et al.
Mammalian DNA nucleotide excision repair re-
constituted with purified protein components. Cell.
 Guzder SN, Habraken Y, Sung P, Prakash L, Prakash
S. Reconstitution of yeast nucleotide excision re-
pair with purified Rad proteins, replication protein
A, and transcription factor TFIIH. J Biol Chem.
 Sugasawa K, Ng JM, Masutani C, et al. Xeroderma pig-
mentosum group C protein complex is the initiator
of global genome nucleotide excision repair. Mol Cell.
 Mellon I, Spivak G, Hanawalt PC. Selective removal
of transcription-blocking DNA damage from the tran-
scribed strand of the mammalian DHFR gene. Cell.
 Henning KA, Li L, Iyer N, et al. The Cockayne syn-
drome group A gene encodes a WD repeat protein that
interacts with CSB and a subunit of RNA polymerase II
TFIIH. Cell. 1995;82(4):555–564.
 van Gool AJ, Citterio E, Rademakers S, et al. The Cock-
ayne syndrome B protein, involved in transcription-
coupled DNA repair, resides in an RNA polymerase II-
containing complex. EMBO J. 1997;16(19):5955–5965.
 de Boer J, Hoeijmakers JH. Nucleotide excision
 Winkler GS, Araujo SJ, Fiedler U, et al. TFIIH with
inactive XPD helicase functions in transcription ini-
tiation but is defective in DNA repair. J Biol Chem.
2:2 (2002) Nucleotide Excision Repair, Genome Stability, and Human Disease. New insight from model systems5
 van Vuuren AJ, Vermeulen W, Ma L, et al. Cor-
rection of xeroderma pigmentosum repair defect by
basal transcription factor BTF2 (TFIIH). EMBO J.
 Bradsher J, Coin F, Egly JM. Distinct roles for the he-
licases of TFIIH in transcript initiation and promoter
escape. J Biol Chem. 2000;275(4):2532–2538.
 Sijbers AM, de Laat WL, Ariza RR, et al. Xero-
derma pigmentosum group F caused by a defect in
a structure-specific DNA repair endonuclease. Cell.
 O’Donovan A, Davies AA, Moggs JG, West SC, Wood
RD. XPG endonuclease makes the 3?incision in human
DNA nucleotide excision repair. Nature. 1994;371:432–
 Kraemer KH, Lee MM, Scotto J. DNA repair pro-
tects against cutaneous and internal neoplasia: evi-
dence from xeroderma pigmentosum. Carcinogenesis.
 Sijbers AM, van Voorst Vader PC, Snoek JW, Raams
A, Jaspers NG, Kleijer WJ. Homozygous R788W point
mutation in the XPF gene of a patient with xeroderma
 Dianov GL, Houle JF, Iyer N, Bohr VA, Friedberg
EC. Reduced RNA polymerase II transcription in ex-
tracts of Cockayne syndrome and xeroderma pigmen-
tosum/Cockayne syndrome cells. Nucleic Acids Res.
 Vermeulen W, Rademakers S, Jaspers NG, et al. A
temperature-sensitive disorder in basal transcription
 de Boer JH, Hoeijmakers J. Cancer from the outside,
aging from the inside: mouse models to study the
consequences of defective nucleotide excision repair.
 Sekelsky JJ, Hollis KJ, Eimerl AI, Burtis KC, Hawley
RS. Nucleotide excision repair endonuclease genes in
Drosophila melanogaster. Mutat Res. 2000;459(3):219–
 Gallego F, Fleck O, Li A, Wyrzykowska J, Tinland B.
AtRAD1, a plant homologue of human and yeast nu-
cleotide excision repair endonucleases, is involved in
dark repair of UV damages and recombination. Plant
 Lee SK, Yu SL, Alexander H, Alexander S. A mutation
in repB, the Dictyostelium homolog of the human xe-
roderma pigmentosum B gene, has increased sensitivity
to UV-light but normal morphogenesis. Biochim Bio-
phys Acta. 1998;1399(2-3):161–172.
 McCready SJ, Osman1 F, Yasui A. Repair of UV damage
in the fission yeast Schizosaccharomyces pombe. Mutat
 Prakash S, Prakash L. Nucleotide excision repair in
yeast. Mutat Res. 2000;451(1-2):13–24.
 Wijnhoven SW, Kool HJ, Mullenders LH, Slater R,
van Zeeland AA, Vrieling H. DMBA-induced toxic
and mutagenic responses vary dramatically between
NER-deficient Xpa, Xpc and Csb mice. Carcinogenesis.
 de Boer J, van Steeg H, Berg RJ, et al. Mouse model for
the DNA repair/basal transcription disorder trichoth-
iodystrophy reveals cancer predisposition. Cancer Res.
 Feaver WJ, Svejstrup JQ, Bardwell L. Dual roles of a
multiprotein complex from S. cerevisiae in transcrip-
tion and DNA repair. Cell. 1993;75(7):1379–1387.
 Drapkin R, Reardon JT, Ansari A, et al. Dual role of
TFIIH in DNA excision repair and in transcription by
RNA polymerase II. Nature. 1994;368(6473):769–772.
 Guzder SN, Sung P, Prakash S, Prakash L. Lethality in
yeast of trichothiodystrophy (TTD) mutations in the
human xeroderma pigmentosum group D gene. Impli-
cations for transcriptional defect in TTD. J Biol Chem.
 Schiestl RH, Prakash S. RAD1, an excision repair gene
of Saccharomyces cerevisiae, is also involved in recombi-
nation. Mol Cell Biol. 1988;8(9):3619–3626.
 Schiestl RH, Prakash S. RAD10, an excision repair
gene of Saccharomyces cerevisiae, is involved in the
RAD1 pathway of mitotic recombination. Mol Cell Biol.
 Fishman-Lobell J, Haber JE. Removal of nonhomolo-
gous DNA ends in double-strand break recombination:
the role of the yeast ultraviolet repair gene RAD1. Sci-
 Bailis AM, Maines S. Nucleotide excision repair gene
function in short-sequence recombination. J Bacteriol.
 Bardwell AJ, Bardwell L, Tomkinson AE, Friedberg EC.
termediates by the yeast Rad1-Rad10 DNA endonucle-
ase. Science. 1994;265(5181):2082–2085.
 Montelone BA, Hoekstra MF, Malone RE. Sponta-
neous mitotic recombination in yeast: the hyper-
recombinational rem1 mutations are alleles of the
RAD3 gene. Genetics. 1988;119(2):289–301.
of multiple yeast rad3 mutant alleles on UV sensitiv-
ity, mutability, and mitotic recombination. J Bacteriol.
 Bailis AM, Maines S, Negritto MT. The essential he-
licase gene RAD3 suppresses short sequence recom-
bination in Saccharomyces cerevisiae. Mol Cell Biol.
 Maines S, Negritto MC, Wu X, Manthey GM, Bailis
AM. Novel mutations in the RAD3 and SSL1 genes per-
tween short repeats in Saccharomyces cerevisiae. Genet-
 Lee BS, Bi L, Garfinkel DJ, Bailis AM. Nucleotide
excision repair/TFIIH helicases RAD3 and SSL2 in-
hibit short-sequence recombination and Ty1 retro-
transposition by similar mechanisms. Mol Cell Biol.
6 D. J. Garfinkel and A. M. Bailis2:2 (2002)
 Gorbalenya AE, Koonin EV, Donchenko AP, Blinov
VM. Two related superfamilies of putative helicases in-
volved in replication, recombination, repair and ex-
pression of DNA and RNA genomes. Nucleic Acids Res.
 Montelone BA, Malone RE. Analysis of the rad3-101
and rad3-102 mutations of Saccharomyces cerevisiae:
implications for structure/function of Rad3 protein.
 Lehmann AR. The xeroderma pigmentosum group D
(XPD) gene: one gene, two functions, three diseases.
Genes Dev. 2001;15(1):15–23.
 Deininger PL, Batzer MA. Alu repeats and human dis-
ease. Mol Genet Metab. 1999;67(3):183–193.
 Weber CA, Salazar EP, Stewart SA, Thompson LH.
ERCC2: cDNA cloning and molecular characterization
of a human nucleotide excision repair gene with high
homology to yeast RAD3. EMBO J. 1990;9(5):1437–
 Sharon G, Burkett TJ, Garfinkel DJ. Efficient homol-
ogous recombination of Ty1 element cDNA when in-
tegration is blocked. Mol Cell Biol. 1994;14(10):6540–
inhibition of Ty1 retrotransposition by nucleotide ex-
cision repair/transcription factor TFIIH subunits Ssl2p
and Rad3p. Genetics. 1998;148(4):1743–1761.
 Rattray AJ, Shafer BK, Garfinkel DJ. The Saccharomyces
cerevisiae DNA recombination and repair functions of
the RAD52 epistasis group inhibit Ty1 transposition.
 Fasullo M, Bennett T, AhChing P, Koudelik J. The
Saccharomyces cerevisiae RAD9 checkpoint reduces
the DNA damage-associated stimulation of directed
translocations. Mol Cell Biol. 1998;18(3):1190–1200.
2Please note that genes and enzymes symbols have to be ital-
icized, while protein symbols are roman, so you are kindly
to ensure that they are correct throughout.
3 The highlighted 3?and 5?mean the third and the fifth?
4 We added “have been” .
5 Please indicate if “Rad3” is a gene name or not.
6 In the legend of Figure 1, we changed “as previously described
” to “as described in ” . Please check.
7 Please review the symbols in the legend of Figure 1, to deter-
mine to us how they should be written, concerning the font
and the capitalization.
8“rad3” is written in 3 different ways till this page, please deter-
mine what each occurrence represents: a gene, a protein, ...,
to help us determining the font we have to use, please note
that, as you know, if a protein and gene have a symbol in
common, the gene is distinguished by italic font and all let-
ters are capitals.
9“ssl2” is written in 2 different ways. Please check.
10 rtt has to be capitalized as it is an acronym, is it ok?
11 Please check this symbol.
12 Should we add “such” after “likelihood” .
13 Please spell out AMB
14 Please provide the issue number for reference .